Profasi® (mfg. Serono), Pregnyl® (mfg. Organon), Novarel® (mfg. Ferring), A.P.L.® (mfg. Wyeth-Ayerst)
Demonstrated ovulatory dysfunction with:
In women, inducing ovulation by stimulating the release of the egg from the follicle. In men, used to treat hypogonadism.
In women, behaves like luteinizing hormone (LH) to assist the corpus luteum in releasing progesterone, which is crucial to preparation of uterine lining for implantation. In men, stimulates Leydig (interstitial) cells of the testes to produce androgens (testosterone).
During a fertility treatment cycle, 5,000 to 10,000 USP units one day after last dose of menotropins or follitropins. For male treatment, 1,000 to 4,000 units two to three times weekly for several weeks.
Must be kept refrigerated. Maintain BBT chart or other recommended cycle charting methods throughout treatment cycle. Ovulation usually occurs approx. 36 hours after injection. Women with luteal phase defect may receive additional injections.
Severe pain or swelling in lower abdomen
No known drug interactions.
© Tracy Morris